“Darolutamide in combination with ADT and docetaxel should become a new standard ... features a distinct chemical structure that competitively inhibits androgen binding, androgen receptor ...

Structure of (ziv-)aflibercept ... Exclusion criteria included the following: prior docetaxel or outright progression on paclitaxel therapy; discontinuation of prior anti-VEGF as a result of drug ...

Lately, structure-activity relationship studies have focused on identifying novel structurally related docetaxel analogues with increased cytotoxicity in resistant tumours, increased penetration ...

The question remains as to whether the chemotherapy drug docetaxel, which increases survival in metastatic prostate cancer, can improve the cure rate in these patients. In a new study by ...

We compared such treatment with docetaxel plus prednisone in men with this disease. From March 2000 through June 2002, 1006 men with metastatic hormone-refractory prostate cancer received 5 mg of ...

January 9, 2008 — A phase 3 randomized clinical trial shows that adding docetaxel (Taxotere, Sanofi-Aventis) after doxorubicin (Adriamycin, Pharmacia) slightly improves disease-free survival in ...

We compared docetaxel plus estramustine with mitoxantrone plus prednisone in men with metastatic, hormone-independent prostate cancer. We randomly assigned 770 men to one of two treatments ...